Company intelligence / Profile preview

CoLabs Inc.

Staten Island, New York, United Statescolabsmedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CoLabs is developing The Ventor, an emergency airway and ventilation system designed to improve patient outcomes during cardiac arrest by streamlining airway management and ventilation in chaotic emergency settings. Early clinical study designs have been approved by the FDA, focusing on improving arterial oxygenation in pre-hospital settings to increase eligibility for advanced therapies like ECMO. The company recently closed a Series B funding round and is preparing for commercialization.

Therapeutic areas: PulmonologyCardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on CoLabs Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoLabs Inc..

Explore the full profile